December 27th 2018EP. 1: Axial Spondyloarthritis Defined
December 27th 2018EP. 2: Epidemiology of Axial Spondyloarthritis
December 27th 2018EP. 3: Accurately Diagnosing Axial Spondyloarthritis
December 27th 2018EP. 4: Unmet Needs in the Diagnosis of Axial Spondyloarthritis
December 27th 2018EP. 5: Axial Spondyloarthritis and Quality of Life
December 27th 2018EP. 6: Establishing Goals of Therapy in Axial Spondyloarthritis
December 27th 2018EP. 7: Clinical Recommendations: Managing Axial Spondyloarthritis
December 27th 2018EP. 8: Treating Axial Spondyloarthritis
December 27th 2018EP. 9: Axial Spondyloarthritis: Future Outlook
December 27th 2018EP. 10: Initial Symptoms of NrAxSpa & Inconclusive Diagnostics
December 27th 2018EP. 11: Timeline of NrAxSpa Onset to Correct Diagnosis
December 27th 2018EP. 12: Ineffective NrAxSpa Treatments
December 27th 2018EP. 13: Living With Untreated NrAxSpa
December 27th 2018EP. 14: The Progression of Nr-AxSpA Symptoms
December 27th 2018EP. 15: The Impact of Certolizumab Pegol in Treating Nr-AxSpA
December 27th 2018EP. 16: Living With NrAxSpa Posttreatment
December 27th 2018EP. 17: The IFAA: Raising Awareness of NrAxSpa & Related Diseases
December 27th 2018EP. 18: Advice for NrAxSpa Patients & Future of Treatment
December 27th 2018EP. 19: Nonradiographic Versus Radiographic Axial Spondyloarthritis
December 27th 2018EP. 20: The Epidemiology of Axial Spondyloarthritis
December 27th 2018EP. 21: Diagnosing Axial Spondyloarthritis
December 27th 2018EP. 22: AxSpa Treatment Goals and Windows of Opportunity
December 27th 2018EP. 23: AxSpa Treatments: TNF Inhibitors, NSAIDs, and Opioids
December 27th 2018EP. 24: The Future of Axial Spondyloarthritis Treatment
